Aurealis Pharma

Finland
Kuopio, North Savo, Finland
+358458433550 ★

Company profile

Aurealis Pharma company profile

Aurealis Pharma is a biopharmaceutical company aiming at developing ground-breaking medicines for the treatment of cancer and chronic wounds. They are dedicated in the R&D of gene and cell based therapies, as well as the development of new active molecules by computational modeling of nature derived compounds. Their key strategy is to perform outstanding interdisciplinary R&D and to implement these into new business models. They are actively seeking for collaborations with pharmaceutical companies, academic research institutions and pre-clinical CROs.

Business identity

Phone number
+358458433550
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$10K+
Founded
2010-04-01

Headquarters

Headquarters
Kuopio, North Savo, Finland
Postal code
70210
Country code
FI
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$13.6M
Last funding
Series B / $7.8M / 2019-02-12
Last equity funding
Series B / $7.8M
Investors
3
Lead investors
2
Founders
3

Founders and investors

Founders

Dirk WeberMarkus forsbergThomas wirth

Lead investors

Business FinlandFinnvera Venture Capital

Investors

Business FinlandFinnvera Venture Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.